A comparison of cisplatin cumulative dose and cisplatin schedule in patients treated with concurrent chemo-radiotherapy in nasopharyngeal carcinoma()

INTRODUCTION: Three-weekly cisplatin dose is accepted for standard treatment for concurrent chemo-radiotherapy in nasopharyngeal carcinoma. However, different chemotherapy schedules are presented in the literature. OBJECTIVE: We intend to compare toxicity and outcomes of high dose 3-weekly cisplatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Gundog, Mete, Basaran, Hatice, Bozkurt, Oktay, Eroglu, Celalettin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422570/
https://www.ncbi.nlm.nih.gov/pubmed/31164277
http://dx.doi.org/10.1016/j.bjorl.2019.04.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422570/
https://www.ncbi.nlm.nih.gov/pubmed/31164277
http://dx.doi.org/10.1016/j.bjorl.2019.04.008

Ejemplares similares